The deeper dive
Medical innovation outpaces medical policy with health insurance plans. That reality can be difficult to accept for companies that have poured significant investment into a new device, drug, or biologic. For health plans, FDA marketing authorization is important, but other
Medical innovation outpaces medical policy with health insurance plans. That reality can be difficult to accept for companies that have poured
Patient access isn’t just reimbursement mechanics — it’s the infrastructure that determines whether life-changing innovation actually reaches patients. Ironically, the burden
You’ve done the hard work. Your medical device has FDA clearance or approval. Clinical data supports its efficacy. Providers are interested.
Technology Now Available for Licensing to Medical Device, Biotechnology, and Pharmaceutical Companies Seeking to Bring Patient Access Operations In-House Access Bridge
Watch Recording Navigating Reimbursement Support Compliance in Med Tech Reimbursement support programs are essential for helping patients access innovative medical technologies,
Last week, Kim Norton, CEO of JDL Access (jdlaccess.com), was invited by Cindy Grabowski, founder of Mind Grove (mindgrove.com) and JD